Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 28, 2023. (Total: 221530Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 4 (of 4 Records)

Query Trace: Thrombocytopenia and IDH1[original query]
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
British journal of haematology 2015 Apr 169 (1): 71-6.
Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
Blood 2014 Apr 123 (14): 2157-60.
Guglielmelli Paola, Biamonte Flavia, Rotunno Giada, Artusi Valentina, Artuso Lucia, Bernardis Isabella, Tenedini Elena, Pieri Lisa, Paoli Chiara, Mannarelli Carmela, Fjerza Rajmonda, Rumi Elisa, Stalbovskaya Viktoriya, Squires Matthew, Cazzola Mario, Manfredini Rossella, Harrison Claire, Tagliafico Enrico, Vannucchi Alessandro M, ,
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
The New England journal of medicine 2018 6 378 (25): 2386-2398.
DiNardo Courtney D, Stein Eytan M, de Botton Stéphane, Roboz Gail J, Altman Jessica K, Mims Alice S, Swords Ronan, Collins Robert H, Mannis Gabriel N, Pollyea Daniel A, Donnellan Will, Fathi Amir T, Pigneux Arnaud, Erba Harry P, Prince Gabrielle T, Stein Anthony S, Uy Geoffrey L, Foran James M, Traer Elie, Stuart Robert K, Arellano Martha L, Slack James L, Sekeres Mikkael A, Willekens Christophe, Choe Sung, Wang Hongfang, Zhang Vickie, Yen Katharine E, Kapsalis Stephanie M, Yang Hua, Dai David, Fan Bin, Goldwasser Meredith, Liu Hua, Agresta Sam, Wu Bin, Attar Eyal C, Tallman Martin S, Stone Richard M, Kantarjian Hagop
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia.
Journal of cancer research and clinical oncology 2022 1 148 (11): 3191-3202.
Fleischmann Maximilian, Scholl Sebastian, Frietsch Jochen J, Hilgendorf Inken, Schrenk Karin, Hammersen Jakob, Prims Florian, Thiede Christian, Hochhaus Andreas, Schnetzke U
TOP